BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17664475)

  • 1. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.
    Lecouvet FE; Geukens D; Stainier A; Jamar F; Jamart J; d'Othée BJ; Therasse P; Vande Berg B; Tombal B
    J Clin Oncol; 2007 Aug; 25(22):3281-7. PubMed ID: 17664475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
    Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
    Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?
    Pasoglou V; Larbi A; Collette L; Annet L; Jamar F; Machiels JP; Michoux N; Vande Berg BC; Tombal B; Lecouvet FE
    Prostate; 2014 May; 74(5):469-77. PubMed ID: 24375774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
    World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metastatic bone disease. Strategies for imaging].
    Scutellari PN; Antinolfi G; Galeotti R; Giganti M
    Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography.
    Schirrmeister H; Guhlmann A; Kotzerke J; Santjohanser C; Kühn T; Kreienberg R; Messer P; Nüssle K; Elsner K; Glatting G; Träger H; Neumaier B; Diederichs C; Reske SN
    J Clin Oncol; 1999 Aug; 17(8):2381-9. PubMed ID: 10561300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.
    Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT
    J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy.
    Cascini G; Falcone C; Greco C; Bertucci B; Cipullo S; Tamburrini O
    Radiol Med; 2008 Dec; 113(8):1157-70. PubMed ID: 18958408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.
    Hetzel M; Arslandemir C; König HH; Buck AK; Nüssle K; Glatting G; Gabelmann A; Hetzel J; Hombach V; Schirrmeister H
    J Bone Miner Res; 2003 Dec; 18(12):2206-14. PubMed ID: 14672356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does iliac crest bone marrow biopsy compare with imaging in the detection of bone metastases in small cell lung cancer?
    Perrin-Resche I; Bizais Y; Buhe T; Fiche M
    Eur J Nucl Med; 1993 May; 20(5):420-5. PubMed ID: 8390936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma.
    Chen CY; Wu K; Lin WH; Lan TY; Wang SY; Sun JS; Weng PW; Yen RF; Yang RS
    J Formos Med Assoc; 2012 Mar; 111(3):140-6. PubMed ID: 22423667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.
    Sohaib SA; Cook G; Allen SD; Hughes M; Eisen T; Gore M
    Br J Radiol; 2009 Aug; 82(980):632-9. PubMed ID: 19221182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer.
    Prior JO; Barghouth G; Delaloye JF; Leyvraz S; Bischof Delaloye A
    Nucl Med Commun; 2003 Jan; 24(1):29-36. PubMed ID: 12501017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study.
    Haubold-Reuter BG; Duewell S; Schilcher BR; Marincek B; von Schulthess GK
    Eur J Nucl Med; 1993 Nov; 20(11):1063-9. PubMed ID: 8287874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of whole body MRI and radioisotope bone scintigram for skeletal metastases detection.
    Chan Y; Chan K; Lam W; Metreweli C
    Chin Med J (Engl); 1997 Jun; 110(6):485-9. PubMed ID: 9594253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases.
    Traill ZC; Talbot D; Golding S; Gleeson FV
    Clin Radiol; 1999 Jul; 54(7):448-51. PubMed ID: 10437696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Technetium-99m Bone Scintigraphy in the Detection of Cervical Spine Metastases in Oncological Patients.
    Park SM; Park JW; Lee HJ; Choi JY; Yoo HJ; Lee CK; Chang BS; Kim H
    Spine (Phila Pa 1976); 2017 Nov; 42(22):1699-1705. PubMed ID: 28368988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.